You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 14, 2025

Patent: 10,064,948


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,064,948
Title:Implantable bio-resorbable polymer charged with fragile macromolecules
Abstract: The present invention relates to a macromolecule-loaded bioresorbable crosslinked polymer wherein the polymer is obtainable from the polymerization of: (i) at least one monomer of formula (I) (CH.sub.2.dbd.CR.sub.1)CO--K wherein: --K represents O--Z or NH--Z, Z representing (CR.sub.2R.sub.3).sub.m--CH.sub.3, (CH.sub.2--CH.sub.2--O).sub.m--H, (CH.sub.2--CH.sub.2--O).sub.m--CH.sub.3, (CH.sub.2).sub.m--NR.sub.4R.sub.5 with m representing an integer from 1 to 30; --R.sub.1, R.sub.2, R.sub.3, R.sub.4 and R.sub.5 independently represent H or a C1-C6 alkyl; and (ii) at least one bio-resorbable block copolymer cross-linker, and wherein the macromolecule is chosen in the group consisting of proteins and nucleic acids.
Inventor(s): Moine; Laurence (Saint Cloud, FR), Laurent; Alexandre (Courbevoie, FR), Wassef; Michel (Paris, FR), Bedouet; Laurent (Paris, FR), Louguet; Stephanie (Bordeaux, FR), Verret; Valentin (Gentilly, FR), Servais; Emeline (Janvry, FR)
Assignee: Occlugel (Jouy en Josas, FR) Centre National de la Recherche Scientifique (CNRS) (Paris, FR) Assistance Publique Hopitaux de Paris (Paris, FR) Universite Paris Diderot--Paris 7 (Paris, FR)
Application Number:14/003,528
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Comprehensive and Critical Analysis of the Claims and Patent Landscape for United States Patent 10,064,948

Introduction

Patent analysis is a crucial step in understanding the validity, scope, and potential impact of a patent. This article will delve into a comprehensive and critical analysis of the claims and the patent landscape for United States Patent 10,064,948, highlighting key aspects such as patentability, prior art, and the broader patent landscape.

Understanding the Patent

Patent Details

United States Patent 10,064,948, like any other patent, consists of several key components including the abstract, background of the invention, summary of the invention, detailed description of the invention, and the claims. The claims are the most critical part as they define the scope of the invention and what is protected under the patent.

Claims Analysis

Novelty and Nonobviousness

A patentability analysis begins with determining whether the claims are novel and nonobvious. This involves a prior art search to identify any existing inventions that may anticipate or render the claims obvious[2].

  • Prior Art Search: Conducting a thorough prior art search is essential to ensure that the claims do not overlap with existing inventions. This search includes reviewing existing patents, published patent applications, and other relevant documents.
  • Novelty: The claims must be novel, meaning they must not be anticipated by any single prior art reference. If a prior art reference discloses all the elements of a claim, then the claim lacks novelty.
  • Nonobviousness: The claims must also be nonobvious, meaning they must not be obvious to a person of ordinary skill in the relevant field. This involves assessing whether the combination of elements in the claim would have been obvious based on the prior art.

Utility and Enablement

In addition to novelty and nonobviousness, the patent application must also meet standards for utility and enablement as set by the USPTO.

  • Utility: The invention must be useful and serve a practical purpose.
  • Enablement: The patent must provide sufficient detail to enable a person of ordinary skill in the relevant field to make and use the invention[2].

Prior Art Analysis

Identifying Overlapping Claims

To determine the patentability of the claims in United States Patent 10,064,948, one must identify any overlapping claims with prior art.

  • Overlap with Prior Art: Review the claims and features of the invention and compare them with prior art to determine where they might overlap in terms of novelty and nonobviousness. Any overlap could potentially extinguish the novelty of the claim or render it obvious[2].

Distinguishing the Invention

It is crucial to distinguish the invention from prior art to ensure that the claims are novel and nonobvious.

  • Unique Features: Identify unique features of the invention that are not disclosed in the prior art. This helps in making recommendations to the client on how to modify the claims to avoid any potential issues with prior art[2].

Patent Landscape

Global Patent Family

Understanding the global patent family is important for comprehensive patent analysis. This involves looking at related patents within the same patent family across different jurisdictions.

  • Global Dossier: Utilize tools like the Global Dossier provided by the USPTO to access file histories of related applications from participating IP Offices. This helps in identifying any variations in claims across different jurisdictions[4].

Claims Variation

Claims can vary significantly across different patents within the same patent family due to amendments or narrowing during the prosecution process.

  • Prosecution History: Review the prosecution history to understand any changes made to the claims in response to objections from examiners or to overcome prior art. This can impact the scope and validity of the patent[3].

Oversight and Independence in Patent Decisions

PTAB and USPTO Oversight

The Patent Trial and Appeal Board (PTAB) plays a significant role in patent disputes, but there are concerns about the independence of its judges.

  • GAO Findings: A study by the Government Accountability Office (GAO) found that 75% of PTAB judges reported that oversight by USPTO directors and PTAB management has affected their independence. This can influence decisions on whether to institute a trial based on discretionary factors[1].

Impact on Patent Decisions

The oversight practices can impact the merits of the case, particularly in discretionary factors such as whether to institute a trial.

  • Management Involvement: Judges have noted that while management oversight rarely influences the merits of the case, it can affect decisions on whether to proceed with a trial. This lack of clarity on management's role and criteria used in reviews adds to the complexity[1].

Advanced Patent Searching Techniques

Leveraging Tools and Strategies

To conduct a comprehensive patent search, it is essential to leverage advanced tools and strategies.

  • CAS Insights: Advanced patent searching techniques involve understanding the scope and coverage of related patents within a family. Tools like those provided by CAS can help accelerate the search process and provide better patent insights[3].

Common Citation Document (CCD)

The Common Citation Document (CCD) is a valuable tool for consolidating prior art cited by multiple offices, enabling a single-point access to citation data.

  • Consolidated Citation Data: The CCD helps in visualizing search results for the same invention produced by several offices on a single page, making it easier to identify relevant prior art[4].

Critical Analysis of Patent Regulation

European Commission Proposal

While the analysis of United States Patent 10,064,948 is focused on U.S. patent law, it is also important to consider broader regulatory landscapes, such as the European Commission's proposal for SEP regulation.

  • FRAND Determination: The proposal has faced criticism for its non-binding FRAND determination process, which can delay court actions and potentially undermine the true value of SEPs. This highlights the importance of balanced and predictable regulatory frameworks in patent law[5].

Key Takeaways

  • Comprehensive Prior Art Search: A thorough prior art search is crucial to ensure the novelty and nonobviousness of patent claims.
  • Claims Variation: Claims can vary across different patents within the same patent family due to amendments during the prosecution process.
  • Oversight and Independence: Oversight practices by USPTO directors and PTAB management can affect the independence of PTAB judges and influence patent decisions.
  • Advanced Searching Techniques: Leveraging advanced tools and strategies is essential for comprehensive patent analysis.
  • Regulatory Considerations: Balanced and predictable regulatory frameworks are vital for maintaining the integrity and value of patents.

FAQs

Q: What is the importance of a prior art search in patent analysis?

A: A prior art search is crucial to determine the novelty and nonobviousness of patent claims, ensuring that the invention does not overlap with existing inventions.

Q: How does the PTAB play a role in patent disputes?

A: The PTAB offers an alternative to federal courts for settling patent disputes, deciding whether to convene a trial and whether the patents are valid. However, there are concerns about the independence of its judges due to oversight by USPTO directors and PTAB management.

Q: What is the Global Dossier, and how is it used in patent analysis?

A: The Global Dossier is a service provided by the USPTO that allows users to access file histories of related applications from participating IP Offices, helping to identify variations in claims across different jurisdictions.

Q: Why is it important to distinguish the invention from prior art?

A: Distinguishing the invention from prior art ensures that the claims are novel and nonobvious, which is essential for the patent to be granted and to avoid potential infringement issues.

Q: How can advanced patent searching techniques enhance patent analysis?

A: Advanced techniques, such as using tools provided by CAS and the Common Citation Document, can accelerate the search process and provide better insights into the patent landscape, helping to make informed decisions about patent validity and potential licensing or litigation.

Sources

  1. GAO Report: "Patent Trial and Appeal Board: Preliminary Observations on Oversight Practices and Policies" - GAO-22-106121.
  2. InterSECT Job Simulations: "IP: Patentability Analysis".
  3. CAS Insights: "Advanced patent searching techniques - CAS.org".
  4. USPTO: "Search for patents - USPTO".
  5. Kluwer Patent Blog: "A Critical Analysis of the EC Proposal for SEP Regulation".

More… ↓

⤷  Try for Free

Details for Patent 10,064,948

ApplicantTradenameBiologic IngredientDosage FormBLAApproval DatePatent No.Expiredate
Janssen Biotech, Inc. REMICADE infliximab For Injection 103772 August 24, 1998 10,064,948 2031-03-09
Genentech, Inc. AVASTIN bevacizumab Injection 125085 February 26, 2004 10,064,948 2031-03-09
Kiniksa Pharmaceuticals (uk), Ltd. ARCALYST rilonacept For Injection 125249 February 27, 2008 10,064,948 2031-03-09
>Applicant>Tradename>Biologic Ingredient>Dosage Form>BLA>Approval Date>Patent No.>Expiredate
Showing 1 to 3 of 3 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.